InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: Jeff4iam4 post# 203998

Monday, 01/26/2015 5:48:53 PM

Monday, January 26, 2015 5:48:53 PM

Post# of 345989
jeff4iam4, an FDA letter for a biotech company is a material event, just as is a SEC letter for a listed company. PPHM is listed hence...

Now, PPHM is of course under no obligation to tell us about every single letters that does not impact the investment, such as a meeting scheduling or so. But if the FDA would communicate something to PPHM that would have consequences as described in those messages (the 'total collapse' doom) then they have 4 days to tell us. So as the FDA will not write TWO letters the same day, we would have know already.

But actually all that is nonsense for another reason:
We have NO BUSINESS with the FDA ones the trial is started according the design and FDA rules & guidelines. This is a DOUBLE BLINDED trial, remember. PPHM hands it over in a kick-off. After that it is the CRO running the show and the data monitoring committee oversee the data.

If this is coded language then this could well mean the EXACT OPPOSITE. PPHM received letter from the FDA that holds content that would make the PPS explode. With the early look-ins that the FDA granted us that would have least have some grounds!

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News